BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith announces an investigation on behalf of Myriad …
Myriad's stock just completed a long-term bottom in May 2017 ... One of those companies with potential is Myriad Genetics (MYGN). Myriad creates genetic tests to screen for genetic cancer risk and other diseases. It’s currently …
Myriad Genetics, Inc. MYGN was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for …
Myriad Genetics Inc. (MYGN) reported fourth quarter EPS of $0.30 after the bell ... Shares finished up by 2.43 at $27.98 on above average volume. The stock broke out of a month and a half long trading range and set nearly a 52-week high.
Many investors appear to be quite bearish on Myriad Genetics, Inc. (MYGN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 48.90% of the float is sold short, suggesting an extreme level of …
Myriad Genetics Inc. MYGN reported adjusted earnings per share (EPS ... It has a four-quarter average earnings surprise of 8.45%. Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the …
Yahoo!11mon